Schedule 13D ownership disclosure

MARKER THERAPEUTICS ORD

Common Stock, Par Value $0.001 · CUSIP: 57055L107

Event date: 2025-08-19

Filing-level shares
641,801.00
Percent of class
4.96%
  • John R. Wilson TTE, John R. Wilson Revocable Trust U/A DTD 08/03/2017Reported CIK 0001755569

    Shares: 641,801.00 · Class: 4.96%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-080957
Form type
SCHEDULE 13D/A
Filer
Marker Therapeutics, Inc.
CIK
CIK 1094038
Filed
Aug 20, 2025
Reporting period
Aug 19, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub